Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
What drives stock market index performance includes macro trends, earnings, and valuation shifts. This overview explains the main forces behind movements.
27,569 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
June brought a notable move in the tech pocket as D-Wave Quantum jumped after a price-target boost from Mizuho. This ...
The AI boom often centers on GPUs and big models, but the true mover is the network that ties data and compute togeth...
A recent SEC filing details Helix Partners exiting its Cinemark stake. This article breaks down what that exit means ...
Can a defense-focused ETF outperform a jet-fueled recovery play in 2026? This deep dive examines PPA and JETS, weighi...
As AI accelerates, blue-collar automation could reshape factory floors. This piece examines which robotics stocks sta...
A cybersecurity-focused ETF bearing the infamous ticker SPAM is delivering strong 2026 gains, tripling the S&P 500's ...
ARKK’s 0.75% expense ratio and a 46-stock lineup delivered a five-year loss, prompting renewed scrutiny of whether ar...
As July opens, traders are eyeing a quiet market mover. This unheralded sector sure has a track record of supporting ...
A high-profile insider move at Navan has investors weighing the stock. This guide breaks down what navan's chief acco...
Rocket Lab isn’t profitable yet, but the space company shows four clear catalysts for investors. Here are practical r...
When a founder sells a sizable stake, investors take note. This article digs into the implications of airbnb co-found...